EconStor >

Search Results

 
for  

Results 31-40 of 60.


Item hits:

DateTitle Authors
2001 Innovation networks in the biotechnology-based sectorsPyka, Andreas / Saviotti, Paolo
2012 The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: Evidence from longitudinal, disease-level dataLichtenberg, Frank / Pettersson, Billie
2006 The perceived value-added of venture capital investors: Evidence from Finnish biotechnology industryMaunula, Mari
2006 Riskirahoituksen merkitys biotekniikka-alalla: Pääomasijoittajien vertailu yritysten näkökulmastaLuukkonen, Terttu / Maunula, Mari
2007 Simulaatio lääkekehitysalan kannattavuudesta ja riskeistäHermans, Raine / Kulvik, Martti
2006 Helsingin seudun klusterit sekä erikoistuminen bioteknologiaan ja logistiikkaanHernesniemi, Hannu / Kulvik, Martti
2006 Coaching' small biotech companies into success: the value-adding function of VCLuukkonen, Terttu / Maunula, Mari
2012 Margins and market shares: Pharmacy incentives for generic substitutionBrekke, Kurt R. / Holmås, Tor Helge / Straume, Odd Rune
2006 Allocative efficiency measurement revisited: Do we really need input prices?Badunenko, Oleg / Fritsch, Michael / Stephan, Andreas
2005 Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&DToole, Andrew A.

Back 1 2 3 4 5 6 Next